Bone tissue engineering by using a combination of polymer/Bioglass composites with human adipose-derived stem cells. by Lu, W et al.
Bone tissue engineering using a combination of polymer/Bioglass
®
 composites with 
human adipose derived stem cells 
 
Wei Lu 
1,2,3#
, Kun Ji
 1,4#
, Jennifer Kirkham 
5,6
, Yu Yan 
7
, Aldo R. Boccaccini 
8
, Margaret 
Kellett 
9
, Yan Jin 
1*
, and X.B. Yang 
2,6*
 
 
1
 Research and Development Center for Tissue Engineering, The Fourth Military Medical 
University, 145 West Changle Road, Xi’an, Shaanxi 710032, P. R. China  
2
 Biomaterials and Tissue Engineering Group, Department of Oral Biology, Leeds Dental 
Institute, University of Leeds, Leeds LS2 9LU, United Kingdom  
3
 Department of Dentistry, The 461 Hospital of PLA, Changchun, Jilin 130021, P. R. China  
4
 Department of Pediatric Dentistry, School of Stomatology, The Fourth Military Medical 
University, 145 West Changle Road, Xi’an, Shaanxi 710032, P. R. China 
5
 Biomineralization Group, Leeds Dental Institute, University of Leeds, Leeds LS2 9LU, 
United Kingdom 
6
 NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds 
LS7 4SA, United Kingdom 
7
 Corrosion and Protection Center, Key Laboratory for Environmental Fracture (MOE), 
University of Science and Technology Beijing, Beijing 100083, P. R. China 
8
 Institute of Biomaterials, University of Erlangen-Nuremberg, 91058 Erlangen, Germany 
9
 Department of Periodontology, Leeds Dental Institute, University of Leeds, Leeds LS2 
9LU, United Kingdom 
  
Running title: Bioglass
® 
and ADSCs for bone tissue engineering  
 
# 
These two authors contribute equally to this work. 
 
* Corresponding author:   
Dr. Xuebin B Yang 
Biomaterials and Tissue Engineering Group, Leeds Dental Institute, University of Leeds 
Leeds, LS2 9LU, UK.  
E-mail: X.B.Yang@leeds.ac.uk  
 
Prof. Yan Jin 
Research and Development Center for Tissue Engineering, School of Stomatology, Fourth 
Military Medical University, Xi’an, Shaanxi, 710032, China.  
E-mail: yanjin@fmmu.edu.cn 
 
Abstract 
Translational research in bone tissue engineering is essential for ‘bench to bedside’ patient 
benefit. However, the idea combination of stem cells and biomaterial scaffolds for bone 
repair/regeneration is still unclear. The aim of this study was to investigate the osteogenic 
capacity of a combination of poly(DL-lactic acid) (PDLLA) porous foams containing 5 and 
40 wt% of Bioglass
®
 particles with human adipose-derived stem cells (ADSCs) in vitro and 
in vivo. Live/dead fluorescent markers, confocal microscopy and scanning electron 
microscopy (SEM) showed that PDLLA/Bioglass
®
 porous scaffolds supported ADSCs 
attachment, growth and osteogenic differentiation, which were confirmed by enhanced 
alkaline phosphatase activity (ALP). Higher Bioglass
®
 content of the PDLLA foams 
increased more ALP activity compared to PDLLA only group. Extracellular matrix 
deposition after 8 weeks in in vitro culture was evident by Alcian blue/Sirius red staining. 
In vivo bone formation was assessed using scaffold/ADSCs constructs in diffusion 
chambers transplanted intraperitoneally into nude mice and recovered after 8 weeks. 
Histological and immunohistochemical assays indicated significant new bone formation in 
the 40 wt% and 5 wt% Bioglass
®
 constructs compared to the PDLLA only group. This 
study indicated the combination of a well-developed biodegradable bioactive porous 
PDLLA/Bioglass
®
 composite scaffold with a high potential stem cells source – human 
ADSCs could be a promising approach for bone regeneration in clinical setting.  
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Abbreviations 
ADSCs adipose-derived stem cells 
ALP alkaline phosphatase activity  
CMFDA 5-chloromethylfluorescein diacetate  
COL-I collagen I  
EthD-1 ethidium homodimer-1 
FCS fetal calf serum 
FDA Food and Drug Administration  
HA hydroxyapatite  
MSCs mesenchymal stem cells  
NBF neutral buffered formalin  
OCN osteocalcin 
PBS phosphate-buffered saline  
PDLLA  poly(DL-lactic acid) 
PGA poly(glycolic acid)  
PLA poly(lactic acid)  
SEM scanning electron microscopy  
TCP tricalcium phosphate  
TIPS thermally induced phase separation  
UV ultraviolet  
αMEM α-modified minimal essential medium 
 
Introduction 
Critical bone defects and fracture non-union remain major challenges in current clinical 
practice (Hofmann et al. 2008; Zong et al. 2010). From a patient’s perspective, the ultimate 
goal is replacement of their damaged/lost bone with autogenous material, harvested with 
minimal donor side morbidity. Traditionally, small defects are covered using autologous 
bone taken from iliac crest or ribs but large bony defects require autografts or allografts 
whose application is limited in terms of material availability and successful tissue 
in-growth (Eppley et al. 2005). Furthermore, allografts carry the risk of disease 
transmission and host immune response (Horner et al. 2010; Saha et al. 2011; Yang et al. 
2006). In contrast, xenografts are in plentiful supply but they carry even greater risks of 
immune rejection and in situ degeneration as well as disease transmission. Tissue 
engineering offers a promising alternative to permanent implants in the repair of damaged 
tissue, through the use of autologous stem cells seeded into a suitable scaffold (Ahsan and 
Nerem 2005; Blaker et al. 2003; Buma et al. 2004; Marot et al. 2010). 
Stem cell populations for producing engineered bone can be obtained from a range of 
different sources such as bone marrow and peripheral blood. Adipose tissue has recently 
been demonstrated as a viable source of stem cells that can differentiate along adipogenic, 
myogenic, chondrogenic, neuronal and osteogenic lineage pathways in vitro (De Ugarte et 
al. 2003; Gabbay et al. 2006; Kokai et al. 2005; Zuk et al. 2002; Zuk et al. 2001) and/or in 
vivo lee (Hicok et al. 2004; Lee et al. 2003; Lee et al. 2010; Parker and Katz 2006; Wang et 
al. 2010; Wosnitza et al. 2007). To date, bone marrow has been the traditional source of 
human multipotent mesenchymal stem cells (MSCs) for skeletal tissue engineering but 
adipose tissue appears to offer an alternative, more readily available and highly accessible 
stem cell source (Mehrkens et al. 2012; Sterodimas et al. 2009).  
Over the past few years, increasing attention has been paid to composite scaffolds 
designed to be both bioresorbable and bioactive for applications in tissue engineering. Such 
scaffolds have comprised of polymers together with bioactive materials (Boccaccini et al. 
2003; Hench and Paschall 1973; Maquet et al. 2004). Ideally, composite scaffolds should be 
porous on the macroscale to allow for cell ingrowth and migration, and on the microscale to 
allow the efficient transport of nutrients/oxygen, as well as the removal of cellular waste 
products (Hutmacher 2000). For bone tissue engineering, composite scaffolds have 
included combinations of poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and other 
bioresorbable polymers combined with hydroxyapatite (HA), tricalcium phosphate (TCP) 
and bioactive glasses or glass-ceramics in various scaffold architectures (Cao and 
Kuboyama 2010; Liao et al. 2009; Ngiam et al. 2009; Saha et al. 2011; Yang et al. 2004; 
Yang et al. 2006). Synthetic bioresorbable polymers based on lactic acid and their 
copolymers have been used in clinical applications such as surgical sutures or drug delivery 
systems for many years and have US Food and Drug Administration (FDA) approval 
(Howard et al. 2002; Peter et al. 1998). However, lactic acid-based synthetic polymers are 
not inherently bioactive and will not bond directly to bone. They are also initially highly 
hydrophobic and lack the mechanical strength required to meet the demands of orthopaedic 
surgery (Cohen et al. 1993; Liu and Ma 2004). The combination of such polymers with a 
bioactive component therefore takes advantage of both the osteoconductive properties 
(bioactivity) of HA, bioactive glasses and their strengthening effect on polymer matrices. A 
composite scaffold system currently being developed is based on PDLLA/Bioglass
®
-filled 
composite foams produced by thermally induced phase separation (TIPS) (Maquet et al. 
2004). Bioactive glasses, such as 45S5 Bioglass
®
, have successfully been used in clinical 
applications for bone restoration and augmentation (Gheysen et al. 1983; Hattar et al. 2002; 
Hench 1988; Hench and Wilson 1986). 45S5 Bioglass
®
 is a commercial bioactive glass 
containing 45% SiO2, 24.5% Na2O, 24.5% CaO and 6% P2O5 (in weight percentage) 
(Hench and Polak 2002). When implanted or in contact with biological/physiological fluids, 
Bioglass
®
 forms tenacious bonds with hard (and sometimes soft) tissue through the rapid 
formation of a thin layer of carbonated hydroxyapatite on the glass surface. This gives rise 
to an adherent interface that resists substantial mechanical forces. These properties of 45S5 
Bioglass
®
 have guided its application in tissue engineering, mainly in combination with 
biodegradable polymers, to produce porous bioactive composites with foam-like structure 
(Boccaccini et al. 2003). Indeed, numerous in vivo and in vitro studies have shown that 
45S5 Bioglass
®
 can stimulate bone regeneration (Bosetti et al. 2003; Gough et al. 2004; 
Livingston et al. 2002; Loty et al. 2001; Tsigkou et al. 2007; Xynos et al. 2000). As a result, 
Bioglass
®
 is said to be both osteoproductive and osteoconductive. Incorporation of Bioglass 
particles in to a biodegradable polymer scaffold can be advantageous as it will impart 
bioactivity to the polymer matrix whilst reducing the autocatalytic degradation of polymers 
such as polylactide (Blaker et al. 2005; Stamboulis et al. 2002). 
We have previously fabricated composite scaffolds through incorporation of different 
concentrations (0, 5, and 40 wt %) of 45S5 Bioglass
®
 particles into PDLLA. These 
composites have been developed into 3D foam-like structures and characterized in terms of 
their chemical and mechanical properties (Maquet et al. 2003; Yang et al. 2006). However, 
there has been no previous detailed in vitro and in vivo investigation evaluating the effect of 
the composites on human ADSCs osteogenic differentiation and extracellular matrix 
deposition and mineralization.  
The aims of this study were to examine the adhesion, growth and differentiation of ADSCs 
on 3D PDLLA/Bioglass
®
 composite foams in vitro and in vivo, and to evaluate their 
potential in bone tissue engineering.  
 
Materials and methods 
All in vivo experiments were performed with the ethical approval of University of Leeds 
Animal Experimentation Ethics Committee under the Home Office project license 
(40/3361). 
 
Cell culture and characterization 
Human adipose-derived stem cells were purchased from Invitrogen (Catalog nos. 
R7788-115), following isolation from human adipose tissue collected during liposuction 
procedures and cryopreservation from primary cultures. Before cryopreservation, the 
ADSCs were expanded for one passage in MesenPRO RS™ Medium. The ADSCs express 
a flow cytometry cell surface protein profile as follows: positive CD29, CD44, CD73, 
CD90, CD105, CD166; negative CD14, CD31, CD45, Lin1 (Invitrogen 2012). ADSCs 
were expanded in α-modified minimal essential medium (αMEM) （Lonza BioWhittaker, 
Belgium）supplemented with 5% fetal bovine serum (FBS) (BioSera, Sussex, UK) and 1% 
penicillin–streptomycin (Sigma, P0781) (basal medium). ADSCs (1×104 cells) were seeded 
into 90 mm culture dishes (Costar, Cambridge, MA, USA) and cloned as previously 
reported (Seo et al. 2004). The cells were plated at a density of 5000 cells/cm
2
 and 
expanded to the fifth passage. These cells were then used for all experiments performed in 
our study. Mesenchymal stem cell surface markers were confirmed for cultured ADSCs 
using fluorescence-activated cell sorting analysis for CD29 and CD44 (eBioscience, San 
Diego, CA, USA) according to the manufacturer’s protocol. The induction of osteogenesis 
and adipogenesis were as previously reported (Lu et al. 2012).  
 
PDLLA/Bioglass
®
 foam scaffolds 
Purasorb
®
 PDLLA (obtained from Purac Biochem, Goerinchem, The Netherlands) with an 
inherent viscosity of 1.62 dl/g was used for the preparation of high porosity foams. 
Bioactivity was introduced using a melt-derived bioactive glass powder (Bioglass
®
 grade 
45S5, US Biomaterials Co., Alachua, FL, USA). The powder had a mean particle size < 5 
µm. The composition of the bioactive glass used was (in wt %): 45% SiO2, 24.5% Na2O, 
24.5% CaO and 6% P2O5. Polymer/Bioglass
®
 porous composites were prepared by 
freeze-drying as previously described (Maquet et al. 2003). Three scaffolds were tested in 
this study. These comprised of two PDLLA/Bioglass
®
 composite scaffolds at two 
concentrations of Bioglass
®
 (5 and 40 wt% by weight) together with a third scaffold 
containing PDLLA foam only (no Bioglass
®
).  
 
Cell culture on PDLLA/Bioglass
®
 composite scaffolds in vitro 
PDLLA and PDLLA/Bioglass
®
 composite scaffolds were sterilized for 20 min each side 
using ultraviolet (UV) (254 nM wavelength) irradiation and cut into about 2 × 2 × 5 mm
3
 
cuboid blocks. The scaffolds were pretreated by incubating in αMEM for 24 h. To 
determine cell adherence, ADSCs were incubated with 5 mM CellTracker
TM
 green 
(5-chloromethylfluorescein diacetate -CMFDA: Molecular Probes, Leiden, The 
Netherlands) for 45 min. CMFDA is only incorporated into the cell cytoplasm of viable 
cells and remains present through at least four cell divisions. The medium was then 
replaced and the cells were incubated for a further hour. Following trypsinisation and 
resuspension in serum-free αMEM, a uniform number of cells (usually 5×105 cells) was 
added to each of the universals containing pre-prepared individual scaffolds (three samples 
per group of scaffolds). Fluorescence images were taken after 5 h and 24 h as required. The 
medium was then removed and the scaffolds were transferred into 12-well plates where 
they were maintained in αMEM supplemented with 5% FBS for up to 8 weeks. Cultures 
were fed every 3 days and maintained at 37℃ and 5% CO2. At various time points up to 8 
weeks, samples were harvested and processed biochemically and histologically. 
 
Fluorescence microscopy and cell adhesion 
Fluorescence images were taken of ADSCs seeded on the different PDLLA/Bioglass
®
 
composite scaffolds (three samples per group) after 5 h and 24 h post-seeding. Images were 
obtained using an inverted microscope (Motic AE31, USA), equipped with a fluorescence 
filter. Three random images were taken per sample, producing a total of nine images for 
each group. Analysis was performed retrospectively using SCANIMAGE software, which 
detects variations in image colour intensity and calculates individual cell parameters based 
on the fluorescence signal per pixel. 
 
Scanning electron microscopy (SEM) 
ADSCs were cultured on different PDLLA/Bioglass
®
 composite scaffolds for 3 weeks as 
described previously. Scaffolds with or without ADSCs were then fixed in 2.5% 
glutaraldehyde overnight and freeze-dried. Samples were coated with 5 μm thickness gold 
and examined by scanning electron microscopy (XL30, Philips).  
 
Live/Dead cytotoxicity assay 
Cytotoxicity of the two PDLLA/Bioglass
®
 composite scaffolds at two concentrations of 
Bioglass
®
 (5 and 40 wt % by weight) together with a third scaffold containing PDLLA 
foam only (no Bioglass
®
) were determined with the Live/Dead cytotoxicity assay. 
CellTracker
TM
 green and ethidium homodimer-1 (EthD-1) (Molecular Probes) were added 
to 6 week cultures of ADSCs on composite scaffolds to determine cell viability (green 
fluorescence) and cell death (red fluorescence) using laser scanning confocal microscopy 
(Leica TCS SP2, Germany). The results represent the mean values of three individual 
samples for each type of scaffold. 
 
Alcian blue/Sirius red staining 
ADSCs were cultured on the three different scaffolds (three samples each group) for 8 
weeks in vitro. Samples were fixed with 10% neutral buffered formalin (NBF) and 
processed to paraffin wax. 5 μm sections were prepared and stained using Weigert’s 
haematoxylin solutions before staining with 0.5% Alcian blue. After treatment with 1% 
molybdophosphoric acid, sections were stained using 0.1% Sirius red (Saha et al. 2013; 
Yang et al. 2006). 
 
Alkaline phosphatase specific activity 
ADSCs were cultured on the three different scaffolds (four samples each group) in 12-well 
tissue culture plates (5×10
5
 cell/scaffold) in basal medium for 4 weeks. Cell-scaffold 
constructs were then washed with 1× phosphate-buffered saline (PBS) and stored at -80℃ 
until required. For each assay, the constructs were cut into small pieces (about 1 × 1 × 1 
mm
3
) and 0.5 mL 0.1% (v/v) Triton X-100 added before freeze/thawing twice. Total cell 
lysis in Triton X-100 was confirmed by light microscopy. Alkaline phosphatase activity was 
measured spectrophotometrically using p-nitrophenylphosphate as substrate in 
2-amino-2-methyl-1-propanol alkaline buffer solution (1.5 M, pH 10.3, at 37℃) and 
reading the absorbance using a mircoplate reader (Dynex MRX II, America). DNA content 
was measured using the PicoGreen® fluorescence reagent according to the manufacturer’s 
instructions (Molecular Probes) (Green et al. 2004). Sample fluorescence was measured 
using a micro-plate reader (Thermo Scientific Fluoroskan Ascent, America) (excitation 
~480 nm, emission ~520 nm) (Yang et al. 2006). Alkaline phosphatase specific activity was 
then expressed as nanomoles of p-nitrophenol/min/ng DNA (Saha et al. 2010).  
 
In vivo studies 
Male MF-1 nu/nu immunodeficient mice were used for all in vivo studies, and were 
purchased from Harlan (Loughborough, UK). ADSCs were trypsinised and seeded, in 
αMEM, onto sterile scaffolds (n=4 for each scaffold: 0%, 5% and 40% Bioglass® in 
PDLLA) for 24 h. Cell-scaffold constructs were then placed into diffusion chambers 
(Diffusion Chamber Kit, Millipore). Intraperitoneal transplantation of the diffusion 
chambers (Saha et al. 2013) was carried out under anaesthesia using a mixture (1:1, vol/vol) 
of Hypnorm (1:4 in sterile water) and Hypnorval (1:1 in sterile water) administered as 
intraperitoneal injections at 7-10 mL/kg body weight. After 8 weeks, the animals were 
sacrificed and the diffusion chambers were retrieved and fixed in 10% NBF for histological 
analysis. 
 
Histology and immunohistochemistry 
After fixation, cell-scaffold constructs were processed to paraffin wax embedding and 5 μm 
sections were prepared using a microtome (Leica 2035, Germany). For histology, sections 
were stained with Alcian blue/Sirius red as described previously and examined 
microscopically with or without polarized light. For immunohistochemical studies, sections 
were rinsed with 1 x PBS and were blocked in 20% normal goat serum for 5 min at room 
temperature. The primary antibodies used were as follows: Anti-collagen I (COL-Ⅰ) 
monoclonal antibody (1:100, Abcam ab6308) and/or Anti-osteocalcin (OCN) polyclonal 
antibody (1:200, Abcam ab35078) were incubated overnight at 4℃ (COL-I) or for 1 hour 
(OCN) at room temperature. Primary antibodies were detected using the Dako REAL 
EnVision second antibody detection system (Dako, Carpinteria, CA, USA). All sections 
were counterstained with Harris’s Haematoxylin. 1 x PBS instead of primary antibodies 
was used as negative control. 
  
Statistical analysis of data 
Values are expressed as mean ± SD. Experiments were performed at least three times and 
results of representative experiments are presented except where otherwise indicated. 
Statistical analysis was performed by analysis of variance and an independent samples 
t-test with SPSS v16.0 software. P values of less than 0.05 were judged to be statistically 
significant. 
 
Results 
Characterisation of ADSCs 
Human ADSCs were identified based on 1) their ability to form adherent clonogenic cell 
clusters of fibroblast-like cells (Fig. 1a); 2) the ability of these cells to undergo osteogenesis 
following induction was indicated by the presence of calcified extracellular matrix 
deposition in ADSCs within 28 days of induction, as confirmed by Alizarin Red staining 
(Fig. 1b); 3) adipogenesis was determined by the presence of intracellular lipid vacuoles as 
indicated by Oil-Red-O staining within 4 weeks of adipogenic induction (Fig. 1c); 4)  
fluorescence-activated cell sorting analysis of ex vivo–expanded ADSCs demonstrated that 
100.0% of the cells stained positive for mesenchymal stem cell surface markers CD29 and 
99.9% for CD44 (Fig. 1d, eE). 
 PDLLA/Bioglass
®
 composite scaffolds support cell attachment and growth 
ADSCs were observed to attach rapidly to each of the scaffold surfaces after 5h of cell 
seeding (Fig. 2a-c). ADSCs adhered and spread well on the scaffolds after 24 h, as 
observed by the change from a rounded shape to a flattened and spread morphology (Fig. 
2d–f). Qualitative analysis of both numbers of cells attached and spreading on each scaffold 
type revealed no significant visual difference between each group. 
 
SEM analysis of PDLLA/Bioglass
®
 scaffolds ± ADSCs 
The effect of Bioglass
®
 content on the structure of the PDLLA/Bioglass
®
 composite 
scaffolds was investigated by varying the Bioglass
®
 content in a PDLLA matrix and the 
resulting scaffolds were viewed using scanning electron microscopy (Fig. 3a-c). All of the 
scaffolds exhibited a high porosity irrespective of Bioglass
®
 concentration. Following 
seeding with ADSCs, adhesion and cell growth could be observed on all of the scaffolds 
after 21 days in culture. The images provided evidence of both cells and extracellular 
matrix on the surfaces of all of the scaffolds (Fig. 3d-f) with extensive matrix deposition 
apparent. 
 
ALP activity of ADSCs on PDLLA/Bioglass
®
 composite scaffolds in vitro 
After 4 weeks of culture in vitro, alkaline phosphatase specific activity of ADSCs in the 40 
wt % Bioglass
®
 constructs was significantly higher compared to that of both the 5 wt% 
Bioglass
®
 group and the PDLLA only (control) group (p < 0.01). In addition, ALSP for 
ADSCs in the 5 wt% Bioglass
®
 constructs was also significantly increased compared to the 
control group (p < 0.05) (Fig. 4).  
 
Cell viability of ADSCs cultured on PDLLA/Bioglass
®
 composite scaffolds 
After 6 weeks of culture in vitro, extensive cellular ingrowth and majority of the cells were 
viable in all of the cell-scaffold constructs (Fig. 5a-c). Furthermore, there were only a few 
dead cells in all of the groups. However, no qualitative differences were apparent between 
the constructs with 0, 5, and 40 wt% Bioglass
®
.  
 
Collagen synthesis of ADSCs on PDLLA/Bioglass
®
 composite scaffolds in vitro 
After 8 weeks culture in vitro, Alcian blue/Sirius red staining revealed an extensive 
collagenous matrix in the 5 wt% and 40 wt% Bioglass
®
 constructs, that was especially 
pronounced in the 40 wt% Bioglass scaffold constructs. In addition, what appeared to be 
collagenous matrix (based on Sirius red staining) was particularly noticeable at the edges of 
the 5 wt% and 40 wt% Bioglass
®
 constructs compared with the PDLLA only control group. 
Ingrowth of ADSCs was also apparently greater in the 5 wt% and 40 wt% Bioglass
®
 
constructs compared with the PDLLA only control group (Fig. 5d-f), though this was not 
quantified.  
 
Histological examinations of cell-scaffold constructs transplanted in vivo 
After 8 weeks in vivo implantation, Alcian blue/Sirius red staining revealed extensive 
collagenous matrix staining throughout all of the constructs examined (Fig. 6a-c). However, 
this was much greater, especially at the edges of the construct, in those constructs 
incorporating 5 wt% and 40 wt% Bioglass
®
 compared with the PDLLA control group. 
Ingrowth of ADSCs in to the 5 wt% and 40 wt% Bioglass
®
 scaffolds was also greater than 
that seen for the PDLLA only control group. Birefringence revealed the presence of highly 
organized collagen fibers in the 5 wt% and 40 wt% Bioglass
®
 constructs but there was little 
evidence for this in the PDLLA control group (Fig. 6d-f). These results were confirmed 
using immunohistochemistry (Fig. 6g–i), where type I collagen staining was greatest in the 
40 wt% Bioglass
®
 constructs. Furthermore, the expression of the bone-associated protein 
osteocalcin (OCN) was apparently very high in the 5 wt% followed by 40 wt% Bioglass
®
 
composites in comparison with the PDLLA controls (Fig. 6j-l). 
 
Discussion 
Composite scaffolds comprising of PDLLA with Bioglass
®
 particle additions are of current 
interest for bone tissue engineering (Blaker et al. 2003; Blaker et al. 2005; Maquet et al. 
2003; Maquet et al. 2004; Roether et al. 2002; Yang et al. 2006). Adipose tissue is an 
abundant source of mesenchymal stem cells, which have shown promise in the field of 
regenerative medicine (Hicok et al. 2004; Lalande et al. 2011; Parker and Katz 2006). 
These cells can be readily harvested in large numbers with low donor-site morbidity. 
During the past decade, numerous studies have provided preclinical data on the safety and 
efficacy of adipose-derived stem cells, supporting the use of these cells in future clinical 
applications. In this study we investigated ADSC cell adhesion, growth, and osteogenic 
differentiation in composites made of PDLLA foams and Bioglass
®
 particle inclusions in 
vitro compared with PDLLA alone. The combination of ADSCs and PDLLA/Bioglass
®
 
foam was also characterized in an immunocompromised animal model. This is the first 
study addressing specifically the effect of 45S5 Bioglass
®
 additions to a polymer composite 
on adipose derived stem cell behavior and their capacity for bone formation. 
A number of studies have showed that human adipose-derived stem cells are an attractive 
source of cells for bone tissue engineering due to their ease of harvest, the low morbidity 
associated with liposuction, and their rapid expansion in vitro (Schaffler and Buchler 2007; 
Tobitan et al. 2011). ADSCs used in this study were purchased commercially and showed 
typical mesenchymal stem cell characteristics, confirmed using multiple differentiation and 
flow cytometry analysis. The results were consistent with previous publications (Lu et al. 
2012; Zuk et al. 2002).   
Cell adhesion to 3D porous scaffolds is important because it directly influences cell 
settlement on the scaffold and subsequent cell spreading, migration, proliferation, growth, 
and differentiation leading to effective scaffold colonization (Anselme 2000; Verrier et al. 
2004). In the present study, adhesion and spreading of human ADSCs on each of the 
materials was observed by fluorescent, confocal, and scanning electron microscopies. The 
results showed that human ADSCs can attach and spread on each of the materials used (Fig. 
2a–f). In addition, SEM examination also indicated that ADSCs anchored tightly on the 
surface of all three different scaffolds and produced large amounts of extracellular matrix 
after 3 weeks culture in vitro (Fig. 3d-f). This indicated that the three scaffold types had all 
successfully facilitated cell attachment and spreading without the need for modification of 
surface chemistry, which was similar to our previous work on human bone marrow stromal 
cells (Yang et al. 2006). The Live/Dead assays indicated that none of the test materials were 
toxic to the cells, and all of the scaffolds were suitable for long term culture with ADSCs in 
vitro. There were no significant difference for the cell attachment and spreading on the 
different scaffold groups, which indicated that the additional Bioglass
® didn’t effect the cell 
attachment. However, the 40 wt% Bioglass
®
 constructs appeared to significantly enhance 
human ADSCs alkaline phosphatase activity compared with the 5 wt% Bioglass
®
 and 
PDLLA only constructs after 4 weeks, suggesting stimulated cell osteogenic differentiation 
towards the osteogenic lineage as ALP activity has been extensively used as one of the 
indicators for stem cell osteogenic differentiation (Birmingham et al. 2012; Mauney et al. 
2004). After 6 weeks in vitro culture, Alcian blue/Sirius red staining revealed that extensive 
collagenous matrix was produced along with the increase of Bioglass
®
 concentration.  
The diffusion chamber system (Horner et al. 2008) used here for the in vivo studies offers 
definite advantages over conventional transplantation techniques in which host cells from 
various tissues would affect the development of the graft. In vivo analysis of 
PDLLA/Bioglass
®
 composites seeded with ADSCs revealed extensive collagen matrix 
formation in the 40 wt% and 5 wt% Bioglass
®
 constructs, indicative of new bone matrix 
formation. This was also confirmed by birefringence and type I collagen and OCN 
immunohistochemistry. Type Ⅰ  collagen is the most abundant bone matrix protein, 
constituting up to 90% of the organic matrix (Young 2003). Its expression and deposition 
play an important role in mineralization and, consequently, bone formation (Tsigkou et al. 
2007). OCN is a bone specific extracellular matrix protein and its expression and synthesis 
reflect a mature osteoblast phenotype, suggesting that the composite scaffolds had 
supported ADSC osteogenesis. These provided direct evidence of that incorporation of 
45S5 Bioglass
®
 into the PDLLA matrix significantly enhanced ADSC osteogenic 
differentiation and bone-associated extracellular matrix deposition. 
To date, there is no standard method to assess the different combination of stem cells and 
biomaterial scaffolds for the efficacy of tissue regeneration. Neuss et al (2008) have 
assessed 7 different stem cells and 19 different polymers for systematic screening assays to 
analyse parameters such as morphology, vitality, cytotoxicity, apoptosis and proliferation 
(Neuss et al. 2008). However, it was hard to conclude which combination could be better 
for which specific tissue regeneration. In this study, we selected a well-developed 
biodegradable bioactive porous PDLLA/Bioglass
®
 composite scaffold and a high potential 
stem cells source – human ADSCs to test their capacity for bone tissue engineering both in 
vitro and in vivo, which provide evidence to guide for clinical translation of these 
technology. Furthermore, a number of studies showed that ADSCs are immunoprivileged 
cells that may be therefore available for cell replacement therapies in HLA-incompatible 
hosts, before and/or after osteogenic differentiation in vitro  (McIntosh et al. 2009; 
Niemeyer et al. 2007; Puissant et al. 2005), which indicate the potential of using allogenic 
ADSC and PDLLA/Bioglass
®
 composite to heal human bone defect in clinical setting, 
although more work needs to be done in this area to develop useful, safe and powerful 
applications of ASCs in the biomedical field (Rada et al. 2009). 
 
 Conclusions 
This study has shown that PDLLA/Bioglass
®
 composite scaffolds can provide appropriate 
surface chemistry, structure and microenvironment to support ADSCs growth and 
osteogenic differentiation for bone matrix formation, which indicated the potential of using 
the combination of a biodegradable bioactive porous PDLLA/Bioglass
®
 composite scaffold 
with human ADSCs for bone regeneration in clinical bone augmentation.  
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 Figure 1. Characterization of human ADSCs. A) ADSCs were capable of forming a 
single-colony cluster when plated at a low cell density. B) Mineralized nodules formation 
by ADSCs after 4 weeks culture in osteogenic inductive conditions, which were confirmed 
by Alizarin red staining. (C) ADSCs formed Oil red O–positive lipid clusters after 4 weeks 
of adipogenic induction. D&E) Flow cytometric analysis of ex vivo–expanded ADSCs 
revealed expression of CD29 (100%) and CD44 (99.9%). Scale bars: 50 μm. 
 
Figure 2. ADSCs attachment and spreading on 3D PDLLA/Bioglass
®
 scaffolds. 
Representative images of viable human adipose derived stem cells (labeled with CMFDA) 
attachment (A-C: 5 hrs after seeding) and spreading (D-F: 24 hrs after seeding) to 
PDLLA/Bioglass
®
 scaffolds. ADSCs adhered and spread well (yellow arrows) on the 
scaffolds after 24 h compare to that at 5 hrs. Scale bars: 50 μm. 
  
Figure 3. SEM images of different PDLLA/Bioglass® composite foams with/without 
ADSCs. SEM micrographs showing the microstructure of  PDLLA composite foam (A & 
D), 5 wt% PDLLA/Bioglass
®
 composite foam (B & E) and 40 wt% PDLLA/Bioglass
®
 
composite foam (C & F). A-C) scaffold alone. D-F) scaffolds with cells after 3 weeks of 
culture. Sale bars: 50 μm. 
 
 
Figure 4. Alkaline phosphatase specific activity of ADSCs on scaffolds with different 
Bioglass
®
 contents. Data obtained after 4 weeks culture of ADSCs on different scaffolds in 
basal media. *p < 0.05, **p < 0.01. 
 
 Figure 5. Cell viability and histological appearance of ADSCs on different 3D 
scaffolds. Confocal microscopy images (a-c) shows the majority of ADSCs maintained 
viable (green colour) with only a few necrotic cells (red colour: yellow arrows) on different 
scaffolds after 6 weeks in vitro culture. Alcian blue/Sirius red staining (d-f) shows collagen 
matrix (red colour) and tissue formation by the ADSCs on/within PDLLA/Bioglass
®
 
composites after 6 weeks in vitro culture. a & d）ADSCs cultured on PDLLA composite 
foam; b & e）ADSCs cultured on 5 wt % PDLLA/Bioglass® composite foam; c & f）ADSCs 
cultured on 40 wt %PDLLA/Bioglass
®
 composite foam). 
  
Figure 6. Histological and immunohistochemical examinations of human ADSCs- 
PDLLA/Bioglass
®
 constructs after 8 weeks in vivo implantation. a-c) Alcian blue/Sirius 
red staining shows collagen matrix (red colour) and tissue formation by ADSCs on/within 
the scaffold in vivo; d-f) Birefringence images shows high organized type I collagen fibers 
(yellow arrows) within the extra cellular matrix; g-i) Type I collagen immunohistochemical 
staining (brown colour), and j-l) OCN immunohistochemical staining (brown colour). Scale 
bars: 100 μm. 
 
